NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development of novel treatments for gastrointestinal diseases and disorders, today reported its financial results and business update for the first quarter ended March 31, 2015.
Help employers find you! Check out all the jobs and post your resume.
